Basic Information
| LncRNA/CircRNA Name | SRGAP3-AS2 |
| Synonyms | NA |
| Region | GRCh38_3:9192493-9194453 |
| Ensemble | ENSG00000228723 |
| Refseq | NR_121663 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | Microarray, qPCR |
| Sample | lung adenocarcinoma tissues, cell lines(H1299, Calu1, SPC-A1, A549, BEAS-2B) |
| Expression Pattern | down-regulated |
| Function Description | In qRT-PCR of LAD samples without and without lymphatic metastasis and ANT lung tissues, the levels of SRGAP3-AS2, EGFEM1P, FAM66E, and HLA-F-AS1 were downregulated, while the levels of LINC00113, AC005009.1, ARHGAP22-IT1 and AC009411.5 were upregulated. |
| Pubmed ID | 30151992 |
| Year | 2018 |
| Title | Microarray expression profile of long non-coding RNAs in human lung adenocarcinoma. |
External Links
| Links for SRGAP3-AS2 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |